A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| P2X Antagonist III (Purinergic Receptor P2X Antagonist III, N- ( (4- (4-Phenylpiperazin-1-yl) tetrahydro-2H-pyran-4-yl) methyl) -2- (phenylthio) nicotinamide) | A phenylthio-nicotinamide that acts as a high affinity P2X7 antagonist (pKi = 8.7 and 7.9, respectively, against 30nM A-804598 for rat and human P2X7 binding) and potently inhibits P2X7-dependent cellular Ca2+ mobilization (pIC50 = 8.3, 7.5, and 7.2, respectively, using 1321N1 expressing human, mouse, or rat P2X7; drug added 0.5 h prior to 3 min 0.25 mM BzATP stimulation), while exhibiting much reduced or little potency toward a panel of 50 ion channels, transporters, and receptors. Although not suitable for oral dosing due to high hepatic extraction ratios, effective delivery and brain P2X7 occupancy can be achieved via s.c. dosing in rats (30mg/kg) in vivo. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. |  Worldwide |
| P2Y14 Antagonist Prodrug 7j hydrochloride | A P2Y14 antagonist prodrug. Grades: 98%. CAS No. 1315308-19-0. Molecular formula: C33H32ClF3N2O3. Mole weight: 597.07. |  |
| P2Y1/P2Y12 antagonist-1 | P2Y1/P2Y12 antagonist-1 (compound 24w) is an orally available dual inhibitor of P2Y1 and P2Y12 with antiplatelet activity. P2Y1/P2Y12 antagonist-1 inhibits ADP-induced platelet aggregation in rabbit plasma with an IC 50 of 4.23 μM. P2Y1/P2Y12 antagonist-1 exhibits potent inhibitory effects in rat thrombosis model. Uses: Scientific research. Group: Signaling pathways. CAS No. 2738381-94-5. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-149454. |  |
| P2Y Antagonist II (1- (2- (2-tert-Butylphenoxy) pyridin-3-yl) -3- (4- (trifluoromethoxy) phenyl) urea, Purinergic Receptor P2Y Antagonist II) | A phenoxypyridinyl-phenylurea that acts as a highly selective P2Y1 antagonist (Ki = 6nM against 0.5nM 2-MeS-ADP for human P2Y1 binding), while displaying much reduced or no affinity toward other P2Y family GPCRs (Ki = ≥2.5uM toward hP2Y14; Ki >15uM toward human P2Y2, P2Y6, P2Y11, and P2Y12). Effectively inhibits 2.5uM ADP-induced platelet aggregation in vitro (IC50 = 2.1uM) and reduces FeCl2-induced carotid artery blood clot formation in anesthetized rats in vivo (10mg/kg/h i.v. infusion) with much less effect toward prolonging cuticle and mesenteric bleeding time when compared to another P2Y12 antagonist Clopidogrel. Pharmackinetic studies reveal only moderate oral bioavailability in rat. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. Molecular Formula: C??H??F?N?O?. US Biological Life Sciences. | Worldwide |
| P300 (1283-1673), GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. |  |
| p300 (C1135-2414) human | recombinant, expressed in insect cells, ?70% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| p300/CBP Inhibitor VI, L002 (4- (4-Methoxyphenyl sulfonyl oxyimino) -2, 6-di methyl -2, 5-cyclohexadien-1-one, GCN5 Inhibitor III, Histone Acetyltransferase Inhibitor IX, PCAF Inhibitor IV) | A cell-permeable phenyl sulfonyl oxyimi nocyclohexadienone compound that acts as a potent, selective, and reversible inhibitor of p300 histone acetyl transferase (IC50 = 1.98uM). Shown to occupy Ac-CoA binding pocket of p300, and less potent to CBP, PCAF, GCN5 and GNAT. Suppresses Histone H3 and H4 acetylation in triple negative breast cancer cell line MDAMB-468 as well as in HCT116 cell line and blocks p300-mediated STAT3 phosphorylation in pancreatic cancer cell line MIA Paca-2. Does neither inhibit the activities of histone deacetylases 1, 6, and 11 nor 8-diverse histone methyltransferases tested (DOT1, EZH1, G9a, PRMT1, SETD2, SET7-9, SMYD2, and SUV39H2). Reported to suppress tumor growth in mice bearing tumor xenografts of MDAMB-468 cell line (at 500ug/100ul, i.p. twice a week). Group: Biochemicals. Grades: Highly Purified. CAS No. 321695-57-2. Pack Sizes: 10mg. Molecular Formula: C??H??NO?S. US Biological Life Sciences. | Worldwide |
| p300-Ch1 (302-531) human | recombinant, expressed in E. coli, ?80% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| p300 human | recombinant, expressed in insect cells, ?70% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| P3-(1-(2-Nitrophenyl)ethyl) adenosine 5?-triphosphate disodium salt | Cas No. 171800-68-3. | |
| P32/98 hemifumarate | P32/98 is a competitive dipeptidyl peptidase IV (DPP IV) inhibitor exhibiting anti-diabetic activity. Study shows that long-term treatment with P32/98 improves glucose tolerance, insulinemia, beta-cell glucose responsiveness, and peripheral insulin sensitivity. Synonyms: (2S,3S)-2-amino-3-methyl-1-(3-thiazolidinyl)-1-Pentanone (2E)-2-butenedioate (2:1). Grades: ≥98%. CAS No. 251572-86-8. Molecular formula: C9H18N2OS·1/2C4H4O4. Mole weight: 260.4. | |
| P-3355 | P-3355 is antibacterial and antifungal antibiotic produced by streptomyces amylovorus. Synonyms: Antibiotic P 3355; P 3355. CAS No. 60046-57-3. Molecular formula: C7H9NO2. Mole weight: 139.15. | |
| p33ING1, His tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| p33ING2, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| p-(3,5-Dichlorophenyl)phosphonic acid | p-(3,5-Dichlorophenyl)phosphonic acid. Uses: Designed for use in research and industrial production. Additional or Alternative Names: (3,5-dichlorophenyl)phosphonic Acid, SureCN4410151, AGN-PC-0078DJ, Phosphonic acid, (3,5-dichlorophenyl)-, KB-207025, 89891-38-3. Product Category: Heterocyclic Organic Compound. CAS No. 89891-38-3. Molecular formula: C6H5Cl2O3P. Mole weight: 226.981862 [g/mol]. Purity: 0.96. IUPACName: (3,5-dichlorophenyl)phosphonic acid. Canonical SMILES: C1=C(C=C(C=C1Cl)Cl)P(=O)(O)O. Product ID: ACM89891383. Alfa Chemistry ISO 9001:2015 Certified. |  |
| p38?, active, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| p38α inhibitor 3 | p38α inhibitor 3 (Comp G7) is a p38α inhibitor that blocks the effectiveness of myoblast differentiation [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 260428-69-1. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-153002. | |
| p38α inhibitor 5 | p38α inhibitor 5 (compound 1) is a PROTAC-type target protein ligand targeting p38 and can be used to synthesize NR-11c (HY-159798) [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2550397-96-9. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-159799. | |
| p38 MAPK-IN-1 | p38 MAPK-IN-1, a naphthyridine N-oxide, is a novel potent and selective inhibitor of p38 MAPK and it was found to have proper balance between potency and pharmacokinetics and excellent action in a chronic model of arthritis for further study in some sorts. Uses: P38 mapk-in-1 is a novel potent and selective inhibitor of p38 mapk and could be useful in studying some sorts of inflammatory conditions. Synonyms: p38alpha-IN-4; p38alpha IN 4; p38alphaIN4; p38alpha inhibitor 4; p38alpha-inhibitor-4; p38 MAP Kinase Inhibitor XI; P38 MAPK-IN-1; CHEMBL1916344; SCHEMBL2077831; BDBM50357886; HY-12839; HY 12839; HY12839. Grades: 95%. CAS No. 1006378-90-0. Molecular formula: C21H15F2N2O. Mole weight: 349.35. | |
| p38 MAPK-IN-2 | An inhibitor of p38 kinase. Synonyms: Ethanone, 1-[4-[5-(4-chloro-2-fluorophenyl)-4-(4-pyrimidinyl)-1H-pyrazol-3-yl]-1-piperidinyl]-2-hydroxy-; 1-[4-[3-(4-chloro-2-fluorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-5-yl]piperidin-1-yl]-2-hydroxyethanone. CAS No. 635725-16-5. Molecular formula: C20H19ClFN5O2. Mole weight: 415.85. | |
| p38 MAPK-IN-4 | p38 MAPK-IN-4 (compound 6) is a p38 MAPK inhibitor with an 50 of 35 nM [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 219138-24-6. Pack Sizes: 500 μg; 1 mg; 5 mg; 10 mg. Product ID: HY-112466. | |
| p38 MAP Kinase Inhibitor - CAS 219138-24-6 | The p38 MAP Kinase Inhibitor, also referenced under CAS 219138-24-6, controls the biological activity of p38 MAP Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| p38 MAP Kinase Inhibitor III - CAS 581098-48-8 | The p38 MAP Kinase Inhibitor III, also referenced under CAS 581098-48-8, controls the biological activity of p38 MAP Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| p38 MAP Kinase Inhibitor IV | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| p38 MAP Kinase Inhibitor IV | p38 MAP Kinase Inhibitor IV is a highly specific ATP-competitive p38α MAPK inhibitor with IC 50 s of 0.13 and 0.55 μM for p38α and p38β MAPK, respectively [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1638-41-1. Pack Sizes: 5 mg. Product ID: HY-112401. | |
| p38 MAP Kinase Inhibitor IV - CAS 1638-41-1 | The p38 MAP Kinase Inhibitor IV, also referenced under CAS 1638-41-1, controls the biological activity of p38 MAP Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| p38 MAP Kinase Inhibitor V - CAS 271576-77-3 | The p38 MAP Kinase Inhibitor V, also referenced under CAS 271576-77-3, controls the biological activity of p38 MAP Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| p38 MAP Kinase Inhibitor VIII - CAS 321351-00-2 | The p38 MAP Kinase Inhibitor VIII, also referenced under CAS 321351-00-2, controls the biological activity of p38 MAP Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| p38 MAP Kinase Inhibitor VII, SD-169 - CAS 1670-87-7 | The p38 MAP Kinase Inhibitor VII, SD-169, also referenced under CAS 1670-87-7, controls the biological activity of p38 MAP Kinase. Group: Fluorescence/luminescence spectroscopy. | |
| p38 MAP Kinase Inhibitor VI, JX401 - CAS 349087-34-9 | The p38 MAP Kinase Inhibitor VI, JX401, also referenced under CAS 349087-34-9, controls the biological activity of p38 MAP Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| p38 MAP Kinase Inhibitor X, BIRB 796 - CAS 285983-48-4 | The p38 MAP Kinase Inhibitor X, BIRB 796, also referenced under CAS 285983-48-4, controls the biological activity of p38 MAP Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications. Group: Fluorescence/luminescence spectroscopy. | |
| p38 MAP Kinase Inhibitor XI (4-(2,4-Difluorophenyl)-8-(2-methylphenyl)-1,7-naphthyridine-7-oxide, 4-(2,4-Difluorophenyl)-8-o-tolyl-1,7-naphthyridine-7-oxide) | A cell-permeable naphthyridine N-oxide compound that acts as a potent, reversible p38alpha MAP kinase inhibitor (IC50 = 68nM) and exhibits excellent selectivity among 54-kinases. It acts on the ATP-binding site plus an adjacent hydrophobic pocket. Exhibits desirable ADME (Absorption, Distribution, Metabolism, and Excretion) profile with good microsomal stability, low toxicity, and low reactivity towards cytochrome P450 isozymes. Shown to inhibit lipopolysaccharide-induced TNF-alpha production in a dose-dependent manner (ED50 of 0.5mg/kg). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| p38 MAP Kinase Inhibitor XIX, Skepinone-L ((2-(2,4-Difluorophenylamino)-7-[2R-,3-dihydroxypropoxy]-10,11-dihydro-dibenzo[a,d]-cyclohepten-5-one)) | A cell-permeable phenylamino-dibenzosuberone-diol with a rigid molecular structure specifically designed to target hydrophobic region I in p38alpha & p38beta, but not in other kinases with bulky entrance-blocking gatekeeper residues. Shown to selectively inhibit p38alpha (IC50 = 5nM; [ATP] = 100uM) and p38beta (97% inhibition at 1uM), while exhibiting little affinity toward 400 other kinase constructs, including p38delta, p38upsilon, Erk1/2/3/4/5/8, JNK1/2/3, and MEK1/2/3/4/6. Shown to prevent cellular HSP27 Ser82 phosphorylation upon p38 activation by Anisomycin in HeLa (IC50 = 25nM) or by TNF-alpha in THP-1 cultures. Unlike the ATP-binding site-targeting BIRB 796 and SB 203580, Skepinone-L does not inhibit JNK-mediated c-Jun or ERK-dependent CREB phosphorylation in THP-1 cultures. Oral administration to D-Gal-sensitized mice is reported to greatly reduce plasma TNF-alpha production upon LPS challenge (by 77%; 3mg/kg p.o.) in vivo. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| p38 MAPK Inhibitor | p38 MAPK inhibitor is a potent inhibitor of p38 MAP kinase with IC50 value of 35 nM. Synonyms: p38 MAP Kinase Inhibitor; p38 Mitogen-activated Protein Kinase Inhibitor; 2-(4-chlorophenyl)-4-(4-fluorophenyl)-5-pyridin-4-yl-1H-pyrazol-3-one. Grades: ≥98%. CAS No. 219138-24-6. Molecular formula: C20H13ClFN3O. Mole weight: 365.8. | |
| p38 MAPK Inhibitor IV | p38 MAPK inhibitor IV is an ATP-competitive inhibitor of p38α/β MAP kinases with IC50 values of 0.13, 0.55, 5.47, and 8.63 μM for p38α, p38β, p38??, and p38δ, respectively. Synonyms: p38 MAP Kinase Inhibitor IV; p38 Mitogen-activated Protein Kinase Inhibitor IV; 2,2'-sulfonylbis(3,4,6-trichlorophenol); 3,4,6-trichloro-2-(2,3,5-trichloro-6-hydroxyphenyl)sulfonylphenol. Grades: ≥98%. CAS No. 1638-41-1. Molecular formula: C12H4Cl6O4S. Mole weight: 456.9. | |
| P- [ (3-Bromo-7-cyano-2-naphthalenyl) difluoromethyl] phosphonic Acid | P- [ (3-Bromo-7-cyano-2-naphthalenyl) difluoromethyl] phosphonic Acid. Group: Biochemicals. Alternative Names: [ (3-Bromo-7-cyano-2-naphthalenyl) difluoromethyl] phosphonic Acid. Grades: Highly Purified. CAS No. 809272-64-8. Pack Sizes: 1mg. Molecular Formula: C12H7BrF2NO3P, Molecular Weight: 362.06. US Biological Life Sciences. | Worldwide |
| P3HT | P3HT. Uses: Designed for use in research and industrial production. Product Category: Dye-Sensitized Solar Cell (DSSC). CAS No. 104934-50-1. Product ID: ACM104934501. Alfa Chemistry ISO 9001:2015 Certified. | |
| P- [ [4- [ (1-Oxodecyl) amino] phenyl] methyl] phosphonic Acid Cyclohexylamine Salt | P- [ [4- [ (1-Oxodecyl) amino] phenyl] methyl] phosphonic Acid Cyclohexylamine Salt. Group: Biochemicals. Grades: Highly Purified. CAS No. 1333318-20-9. Pack Sizes: 50mg. Molecular Formula: C23H41N2O4P, Molecular Weight: 440.56. US Biological Life Sciences. | Worldwide |
| p-[[4-[Bis(2-hydroxyethyl)amino]-O-tolyl]azo]-N-(2-chloroethyl)benzenesulphonamide | p-[[4-[Bis(2-hydroxyethyl)amino]-O-tolyl]azo]-N-(2-chloroethyl)benzenesulphonamide. Uses: Designed for use in research and industrial production. Additional or Alternative Names: p-[[4-[bis(2-hydroxyethyl)amino]-o-tolyl]azo]-N-(2-chloroethyl)benzenesulphonamide;4-[[4-[Bis(2-hydroxyethyl)amino]-2-methylphenyl]azo]-N-(2-chloroethyl)benzenesulfonamide;Benzenesulfonamide, 4-((4-(bis(2-hydroxyethyl)amino)-2-methylphenyl)azo)-N-(2-chlo. Product Category: Heterocyclic Organic Compound. CAS No. 14607-25-1. Molecular formula: C19H25ClN4O4S. Mole weight: 440.9442. Product ID: ACM14607251. Alfa Chemistry ISO 9001:2015 Certified. Categories: EINECS 238-644-1. | |
| P-4-pyridinyl-Phosphonic acid | P-4-pyridinyl-Phosphonic acid. Group: Customizable mof linkers. Alternative Names: 4-Pyridylphosphonic acid; Phosphonic acid, 4-pyridinyl-. CAS No. 58816-01-6. Product ID: pyridin-4-ylphosphonic acid. Molecular formula: 159.08. Mole weight: C5H6NO3P. InChI=1S/C5H6NO3P/c7-10(8, 9)5-1-3-6-4-2-5/h1-4H, (H2, 7, 8, 9). MRIJGWKJWWKGKW-UHFFFAOYSA-N. 95%. |  |
| P5091 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| P51 Polycarbonate 3D Printing Filament | P51 Polycarbonate 3D Printing Filament. Group: 3d printing materials. | |
| p52 human | recombinant, expressed in E. coli, ?70% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| p53 (103-111) | P53 has been described as ''the guardian of the genome'' because of its role in conserving stability by preventing genome mutation. Suppression of p53 in human breast cancer cells is shown to lead to increased CXCR5 chemokine receptor gene expression and activated cell migration in response to chemokine CXCL13. Synonyms: Cellular tumor antigen p53 (103-111); NY-CO-13 (103-111); Tumor suppressor p53 (103-111). | |
| p53 (1-342) C-terminal deletion human | recombinant, expressed in insect cells, ?80% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| p53 (139-147) | P53 has been described as ''the guardian of the genome'' because of its role in conserving stability by preventing genome mutation. Suppression of p53 in human breast cancer cells is shown to lead to increased CXCR5 chemokine receptor gene expression and activated cell migration in response to chemokine CXCL13. Synonyms: Cellular tumor antigen p53 (139-147); NY-CO-13 (139-147); Tumor suppressor p53 (139-147). | |
| p53 (149-157) | P53 has been described as ''the guardian of the genome'' because of its role in conserving stability by preventing genome mutation. Suppression of p53 in human breast cancer cells is shown to lead to increased CXCR5 chemokine receptor gene expression and activated cell migration in response to chemokine CXCL13. Synonyms: Cellular tumor antigen p53 (149-157); NY-CO-13 (149-157); Tumor suppressor p53 (149-157). | |
| p53 17-26 | P53 (17-26) is the 17-26 amino acid fragment of P53. P53 (17-26) is the mdm-2-binding domain. Synonyms: H-Glu-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu-Leu-OH; L-alpha-glutamyl-L-threonyl-L-phenylalanyl-L-seryl-L-alpha-aspartyl-L-leucyl-L-tryptophyl-L-lysyl-L-leucyl-L-leucine; (2S, 5S, 8S, 11S, 14S, 17S, 20S, 23S, 26S, 29S)-11-((1H-indol-3-yl)methyl)-29-amino-8-(4-aminobutyl)-23-benzyl-17-(carboxymethyl)-26-((R)-1-hydroxyethyl)-20-(hydroxymethyl)-2, 5, 14-triisobutyl-4, 7, 10, 13, 16, 19, 22, 25, 28-nonaoxo-3, 6, 9, 12, 15, 18, 21, 24, 27-nonaazadotriacontane-1, 32-dioic acid. Grades: ≥95%. CAS No. 488118-64-5. Molecular formula: C60H90N12O17. Mole weight: 1251.43. | |
| p53 (1-81), mutant, GST tagged human | recombinant, expressed in E. coli, ?80% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| p53 (1-81), wild type, GST tagged human | recombinant, expressed in E. coli, ?80% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| p53 and MDM2 proteins-interaction-inhibitor chiral | p53 and MDM2 proteins-interaction-inhibitor chiral is an inhibitor of the interaction between p53 and MDM2 proteins. Synonyms: 2-[4-[[(4S,5R)-4,5-bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl]carbonyl]-1-piperazinyl]-1-(4-morpholinyl)Ethanone;Ethanone, 2-[4-[[(4R,5S)-4,5-bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl]carbonyl]-1-piperazinyl]-1-(4-morpholinyl)-, rel-;p53 and MDM2 proteins-interaction-inhibitor. Grades: 95%. CAS No. 939981-37-0. Molecular formula: C40H49Cl2N5O4. Mole weight: 734.76. | |
| p53 and MDM2 proteins-interaction-inhibitor dihydrochloride | p53 and MDM2 proteins-interaction-inhibitor dihydrochloride is an inhibitor of the interaction between p53 and MDM2 proteins. Uses: Scientific research. Group: Signaling pathways. CAS No. 2070009-27-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 100 mg. Product ID: HY-70027A. | |
| p53 and MDM2 proteins-interaction-inhibitor racemic | p53 and MDM2 proteins-interaction-inhibitor racemic is an inhibitor of the interaction between p53 and MDM2 proteins. Synonyms: rel-2-[4-[[(4R,5S)-4,5-Bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl]carbonyl]-1-piperazinyl]-1-(4-morpholinyl)ethanone;Ethanone, 2-[4-[[(4R,5S)-4,5-bis(4-chlorophenyl)-2-[4-(1,1-diMethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-diMethyl-1H-iMidazol-1-yl]carbonyl]-1-piperazinyl]-1-(4-Morpholinyl)-;2-[4-[(4R,5S)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethylimidazole-1-carbonyl]piperazin-1-yl]-1-morpholin-4-ylethanone. Grades: 95%. CAS No. 939983-14-9. Molecular formula: C40H49Cl2N5O4. Mole weight: 734.76. | |
| p53-MDM2-IN-1 | p53-MDM2-IN-1 (Example 30) is an inhibitor of p53-MDM2/X protein interaction with an K i value of 23.35 μM. p53-MDM2-IN-1 can be used for anti-tumor research [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 381717-91-5. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-W340839. | |
| p53-MDM2-IN-4 | p53-MDM2-IN-4 (Example 4) is an inhibitor of p53-MDM2/X protein interaction, with a K i value of 3.079 μM. p53-MDM2-IN-4 can be used in anti-tumor research [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 350678-63-6. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-W340313. | |
| p53-Snail binding Inhibitor, GN25 | The p53-Snail binding Inhibitor, GN25 controls the biological activity of p53-Snail. This small molecule/inhibitor is primarily used for Neuroscience applications. Group: Fluorescence/luminescence spectroscopy. | |
| p5 Ligand for Dnak and DnaJ acetate | p5 Ligand for Dnak and DnaJ acetate is a high-affinity ligand for DnaK (E. coli Hsp70) and DnaJ (E. coli Hsp40) and corresponds to the main binding site of the 23 residues part of the prosequence of mitochondrial aspartate aminotransferase. Synonyms: H-Cys-Leu-Leu-Leu-Ser-Ala-Pro-Arg-Arg-OH.CH3CO2H; L-Cysteinyl-L-leucyl-L-leucyl-L-leucyl-L-seryl-L-alanyl-L-prolyl-L-arginyl-L-arginine acetate salt; L-cysteinyl-L-leucyl-L-leucyl-L-leucyl-L-seryl-L-alanyl-L-prolyl-L-arginyl-L-arginine acetic acid. Grades: ≥95%. CAS No. 2803415-96-3. Molecular formula: C44H81N15O11S.C2H4O2. Mole weight: 1088.33. | |
| p63, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| p70S6K, active, His tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| p70S6K active human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| p70S6Kb, active, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| P-725C | P-725C is a prostaglandin synthetase inhibitor produced by Penicillum thomii. Synonyms: 6-Hydroxy-2-methyl-5-(1-oxopropyl)-2H-1,4-oxazine-3-carboxylic acid. CAS No. 87979-96-2. Molecular formula: C9H11NO5. Mole weight: 213.19. | |
| p73a, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| P73b, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| P73g, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| p75-CTR (C-terminal region) human | recombinant, expressed in E. coli, ?80% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| p75 human | recombinant, expressed in E. coli, ?70% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| P7C3 | P7C3 is a proneurogenic and neuroprotective agent that activates NAMPT. P7C3 protects neurons from apoptosis and promotes neurogenesis in mice. It also improves cognitive function and memory in aged mice. Synonyms: 1-Anilino-3-(3,6-dibromocarbazol-9-yl)propan-2-ol; 1-(3,6-Dibromo-carbazol-9-yl)-3-phenylamino-propan-2-ol; 1-(3,6-dibromo-9H-carbazol-9-yl)-3-(phenylamino)propan-2-ol; 1-(3,6-dibromocarbazol-9-yl)-3-(phenylamino)propan-2-ol. Grades: >98%. CAS No. 301353-96-8. Molecular formula: C21H18Br2N2O. Mole weight: 474.196. | |
| P7C3 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| P7C3 | P7C3. Group: Biochemicals. Grades: Purified. CAS No. 301353-96-8. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
